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scores (P=0.012), Average Pain (P=0.047), Pain Now (P=0.054), 
Pain Interference with Walking Ability (P=0.026), and Pain Inter- 
ference with Enjoyment of Life (P=0.015). SF-36v2 Physical Com- 
ponent Scores were improved 56% greater in the PF group com- 
pared to the GC group (P=0.192). After eight weeks, 100% of 
PF and 79% of GC subjects reported decreased joint pain (by 
WOMAC Pain subscale and Pain Relief Diary). For all measure- 
ments and time points, the average difference between GC and 
PF groups was 3.8x when PF group values were improved com- 
pared to GC group (P=0.014 by log-transformed t test). 
It may be tentatively concluded that a proprietary dietary sup- 
plement formula containing glucosamine, an herbal extract and 
hyaluronate led to significantly larger improvements in parame- 
ters of joint health and quality of life than the combination of glu- 
cosamine and chondroitin sulfate over an eight week period. 
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As part of a larger study of five supplements and placebo, ex- 
ploratory comparisons of changes in symptoms of subjects with 
knee osteoarthritis between specific product groups were per- 
formed. Eighteen subjects took 1500 mg glucosamine HCI and 
1200 mg chondroitin sulfates (GC) and seventeen subjects took 
1500 mg glucosamine HCI, 1200 mg chondroitin sulfates with 
3.3 mg sodium hyaluronate (GCHA) in twelve capsules daily for 
eight weeks. Molecular weight of sodium hyaluronate was approx- 
imately one million daltons. WOMAC, SF-36v2, Brief Pain Inven- 
tory and Pain Relief Diary outcomes were measured at 0, 1,2, 4, 
and 8 weeks. After a one-way ANOVA (using intent-to-treat data) 
on all six groups indicated the presence of significant between- 
group differences, post-hoc comparisons of the changes from 
baseline between the GC and MFHA groups were performed by 
Student t, Mann-Whitney U, and Fisher Exact tests. 
There were four dropouts in the GC and seven in the GCHA group 
(P=0.289). After one week, GCHA group showed greater im- 
provement in efficacy measurements compared to the GC group, 
but differences were not significant until weeks 4-8. WOMAC 
Pain scores at eight weeks for GCHA group were improved 2.3x 
compared to GC group (P=0.089), and WOMAC Total scores for 
GCHA group were improved 2.0x those of GC group (P=0.197). 
Brief Pain Inventory measurements favored GCHA group after 4 
weeks, with Pain Now, Interference with General Activity, Inter- 
ference with Mood, Interference with Walking Ability, Interference 
with Relations to Others, and Interference with Enjoyment of Life 
values showing significant improvements compared to GC group 
values. For all efficacy measurements and all time points, GCHA 
group values were significantly improved from baseline more of- 
ten than GC group values (P<0.0001 by Fisher Exact test). For 
all measurements and all time points, the average difference be- 
tween GCHA and GC groups was 4.68x when GCHA group val- 
ues were improved compared to GC group values (P=0.033 by 
Mann-Whitey U test). 
It may be tentatively concluded that addition of high-molecular 
weight hyaluronate to glucosamine and chondroitin led to signifi- 
cantly larger improvements in parameters of joint health and qual- 
ity of life than the combination of glucosamine and chondroitin 
sulfate over an eight week period. 
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Introduction: Human menisci do not regenerate biomechanically 
competent or functional tissue after partial meniscectomy, the 
most common arthroscopic procedure performed by orthopaedic 
surgeons. Loss of meniscus tissue leads to abnormal biomechan- 
ical stresses on the chondral surfaces, often leading to degenera- 
tive osteoarthritis. The purpose of this study was to determine the 
amount of new tissue growth in patients in a randomized clinical 
trial of the Collagen Meniscus Implant (CMI) after partial medial 
meniscectomy and placement of the CMI to fill the meniscus de- 
fect compared to partial meniscectomy alone. 
Methods: Patients between 18 and 60 years of age who had un- 
dergone one to three prior partial medial meniscectomies yet had 
clinical symptoms of meniscus pathology were randomized either 
to receive the CMI or to have an additional partial meniscectomy 
(control). Twenty-one consecutive patients who met all inclusion 
criteria and had a minimum 1 -year follow-up were included. There 
were 12 CMI and 9 control patients. At index surgery, size of the 
meniscus defect was measured using specially designed instru- 
ments, and the percent of meniscus loss was calculated based 
on actual measurements. All 12 CMI patients underwent relook 
arthroscopy at one year, but control patients did not have a relook. 
At relook, the same instrumentation was used to measure the 
amount of meniscus defect filled with new tissue as a result of the 
CMI. Percent meniscus gain was calculated by multiplying the % 
meniscus loss by the % defect filled, then dividing that product by 
the difference of 100% less the % meniscus loss. 
Results: Based on direct measurements, CMI patients lost on av- 
erage 77% of their native medial meniscus, thus 23% remained. 
The control patients lost on average 75% of their medial menis- 
cus and had 25% remaining. There was no statistical difference 
between groups. It was assumed that control patients regained 
no new tissue over time based on historical controls. At 1-year 
relook, CMI patients had on average 71% of their original defect 
still filled by new tissue compared to no filling assumed in the con- 
trols. Based on the above formula, CMI patients averaged 292% 
gain in meniscus tissue compared to their original remnant. This 
difference was statistically significant (p=0.001) using an inde- 
pendent -test. 
Conclusion: The CMI supports formation of new tissue that fills 
the meniscus defect into which it is placed. The increased percent 
of meniscus gain and total amount of meniscus tissue in CMI 
patients after one year is highly statistically significant compared 
to partial meniscectomy alone. 
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Physical activities are an especially important factor in either cau- 
sation of or protection against osteoarthritis. In animal studies, 
physical activity has had variable effects (from trophic to delete- 
